$NDRA Honestly, if Endra management says they're looking for non-dilutive financing, then I believe that they'll try. I'm not going to argue over it. They either succeed or fail - that's not in my hands. In the end, even if they dilute, my goal is to buy into a company that is disruptive and brings a product that has a clear medical use, which Endra satisfies. Why? As one of the investors in the company that I started told me: "It's better to own a small piece of a very large pie than a large piece of a very small pie." Dilution isn't a bad thing, if it results in the pie getting bigger... and clearly the expansion of Endra's pie happens at commercialization. Everyone who's busy freaking out about dilution is forgetting that this is their last hurdle before beginning sales. Why argue over it? If you don't understand the results, you don't understand the market or don't understand the company, maybe it's time you invest elsewhere. <cough>James<cough>
  • 10
  • 10